CDEK
← All organizations

Molecular Insight Pharmaceuticals

For profitContributed to NME

Also known as: Molecular Insight Pharmaceutical Employee | Molecular Insight Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2006

Last known activity

Nov 8, 2016

Acquired by Progenics → Lantheus Medical Imaging on Jan 1, 2013

Timeline

1990s

  1. Jan 1, 1997

    Molecular Insight Pharmaceuticals— Founded

2010s

  1. Jan 1, 2013

    Progenics— Acquired By

  2. Oct 2, 2019

    Lantheus Medical Imaging— Now

Drugs by trial phase (10 distinct, 18 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (20)

Details

Founded
Boston, MA, US Jan 1, 1997
Last known activity
Nov 8, 2016